Determining whether you should purchase McKesson Corporation (NYSE: MCK) stock requires a careful review of your personal financial situation, risk tolerance, and investment timeline. McKesson is a heavyweight leader in healthcare supply chain management, pharmaceutical distribution, and oncology care services, boasting a robust history of steady revenue generation, strategic share buybacks, and reliable cash flows. While institutional analysts frequently highlight its defensive market positioning and strong long-term growth outlook, potential risks include regulatory scrutiny over drug distribution, pricing pressures, and healthcare policy shifts. You should consult a licensed financial advisor and review recent earnings reports before buying.